chlorogenic-acid has been researched along with Obesity* in 3 studies
3 other study(ies) available for chlorogenic-acid and Obesity
Article | Year |
---|---|
Limosilactobacillus reuteri and caffeoylquinic acid synergistically promote adipose browning and ameliorate obesity-associated disorders.
High intake of caffeoylquinic acid (CQA)-rich dietary supplements, such as green coffee bean extracts, offers health-promoting effects on maintaining metabolic homeostasis. Similar to many active herbal ingredients with high pharmacological activities but low bioavailability, CQA has been reported as a promising thermogenic agent with anti-obesity properties, which contrasts with its poor oral absorption. Intestinal tract is the first site of CQA exposure and gut microbes might react quickly to CQA. Thus, it is of interest to explore the role of gut microbiome and microbial metabolites in the beneficial effects of CQA on obesity-related disorders.. Oral CQA supplementation effectively enhanced energy expenditure by activating browning of adipose and thus ameliorated obesity-related metabolic dysfunctions in high fat diet-induced obese (DIO) mice. Here, 16S rRNA gene amplicon sequencing revealed that CQA treatment remodeled the gut microbiota to promote its anti-obesity actions, as confirmed by antibiotic treatment and fecal microbiota transplantation. CQA enriched the gut commensal species Limosilactobacillus reuteri (L. reuteri) and stimulated the production of short-chain fatty acids, especially propionate. Mono-colonization of L. reuteri or low-dose CQA treatment did not reduce adiposity in DIO mice, while their combination elicited an enhanced thermogenic response, indicating the synergistic effects of CQA and L. reuteri on obesity. Exogenous propionate supplementation mimicked the anti-obesity effects of CQA alone or when combined with L. reuteri, which was ablated by the monocarboxylate transporter (MCT) inhibitor 7ACC1 or MCT1 disruption in inguinal white adipose tissues to block propionate transport.. Our data demonstrate a functional axis among L. reuteri, propionate, and beige fat tissue in the anti-obesity action of CQA through the regulation of thermogenesis. These findings provide mechanistic insights into the therapeutic use of herbal ingredients with poor bioavailability via their interaction with the gut microbiota. Video Abstract. Topics: Adiposity; Animals; Diet, High-Fat; Limosilactobacillus reuteri; Mice; Mice, Inbred C57BL; Obesity; Propionates; RNA, Ribosomal, 16S | 2022 |
Effects of Dicaffeoylquinic Acids from Ilex kudingcha on Lipid Metabolism and Intestinal Microbiota in High-Fat-Diet-Fed Mice.
Kudingcha made from the leaves of Ilex kudingcha and chlorogenic acid have antiobesity and intestinal microbiota modulating effects. However, the effects of kudingcha dicaffeoylquinic acids (diCQAs) on obesity and intestinal microbiota are still poorly understood. In the present study, the effects of kudingcha diCQAs on adipose accumulation and intestinal microbiota were investigated in high-fat-diet-fed mice. As a result, kudingcha diCQAs decreased the liver and adipose tissue masses, concentrations of serum inflammatory factors, and hepatic expressions of lipid synthesis related genes and increased the expressions of genes involved in lipid degradation in the liver. Kudingcha diCQAs also exhibited considerable effects on intestinal microbiota. They increased the relative abundances of Bifidobacterium and Akkermansia and affected the function of the microbial community including bile acid biosynthesis. Kudingcha diCQAs had antiobesity potential, possibly acting through affecting intestinal microbiota. Furthermore, the effects of kudingcha diCQAs on fat accumulation and intestinal microbiota had a dose-dependent manner. Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Bacteria; Diet, High-Fat; Gastrointestinal Microbiome; Humans; Ilex; Intestines; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Quinic Acid | 2019 |
Evaluation of Asteraceae herbal extracts in the management of diabetes and obesity. Contribution of caffeoylquinic acids on the inhibition of digestive enzymes activity and formation of advanced glycation end-products (in vitro).
The study was performed to assess, for the first time, the in vitro anti-diabetic potential of ten Asteraceae plant extracts to inhibit the activity of digestive enzymes (α-amylase, α-, β-glucosidases and lipase) responsible for hydrolysis/digestion of sugar and lipids. Prevention of advanced glycation end-products (AGEs) formation was evaluated in bovine serum albumin/ribose glycation reaction model. The phytochemical profiles and caffeoylquinic acids (CQAs) contents were determined for the methanolic extract of each plant. Analyzed plant extracts exhibited significant inhibitory activity against key digestive enzymes linked to type II diabetes and obesity. A strong inhibition was observed for glucosidases and mild activity towards amylase and lipase (compared to reference compounds). Moreover, some extracts exhibited potent ability to prevent formation of AGEs, implicated in some diabetic complications. Caffeoylquinic acids were dominant in all plant extracts and findings demonstrate that these compounds are the most relevant hypoglycemic and anti-glycation agents. From the obtained results, Argyranthemum pinnatifidum, Helichrysum melaleucum, and Phagnalon lowei are good candidates for further development of phyto-pharmaceutical preparations as complementary therapy for diabetes and obesity control. Topics: alpha-Amylases; Antioxidants; Asteraceae; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Hypoglycemic Agents; Obesity; Phytotherapy; Plant Extracts; Quinic Acid | 2017 |